Edmund Fay Sells 11,937 Shares of Encompass Health (NYSE:EHC) Stock

Encompass Health Corporation (NYSE:EHC) Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at $9,557,775. This represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Encompass Health Trading Down 6.0%

EHC stock opened at $100.50 on Thursday. The firm has a fifty day moving average price of $103.81 and a 200 day moving average price of $113.28. Encompass Health Corporation has a fifty-two week low of $92.53 and a fifty-two week high of $127.99. The firm has a market cap of $9.99 billion, a PE ratio of 18.14, a price-to-earnings-growth ratio of 2.05 and a beta of 0.71. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 5th. The company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a net margin of 9.54% and a return on equity of 18.20%. The company had revenue of $3.09 billion for the quarter, compared to the consensus estimate of $1.54 billion. During the same quarter in the prior year, the firm earned $1.17 earnings per share. Encompass Health’s revenue was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. Sell-side analysts anticipate that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be issued a $0.19 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.8%. Encompass Health’s dividend payout ratio (DPR) is presently 13.72%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday, January 18th. Barclays lifted their target price on Encompass Health from $150.00 to $153.00 and gave the stock an “overweight” rating in a report on Friday, February 6th. Finally, Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus price target of $143.29.

Hedge Funds Weigh In On Encompass Health

Several hedge funds have recently added to or reduced their stakes in EHC. Citizens National Bank Trust Department bought a new stake in Encompass Health in the third quarter worth about $26,000. First Horizon Corp purchased a new stake in shares of Encompass Health in the third quarter worth approximately $34,000. Westside Investment Management Inc. raised its holdings in shares of Encompass Health by 56.7% in the third quarter. Westside Investment Management Inc. now owns 279 shares of the company’s stock worth $35,000 after buying an additional 101 shares during the period. Assetmark Inc. lifted its stake in shares of Encompass Health by 88.1% during the 3rd quarter. Assetmark Inc. now owns 299 shares of the company’s stock worth $38,000 after acquiring an additional 140 shares during the last quarter. Finally, Root Financial Partners LLC purchased a new position in Encompass Health during the 3rd quarter valued at $39,000. 97.25% of the stock is currently owned by institutional investors.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.